Ya Cao Selected Research

Transferases

6/2019	PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
1/2017	Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study.
1/2002	[Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya Cao Research Topics

Disease

167	Neoplasms (Cancer) 04/2024 - 01/2002
73	Nasopharyngeal Carcinoma 10/2023 - 01/2000
33	Carcinogenesis 11/2021 - 01/2002
31	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2002
27	Hepatocellular Carcinoma (Hepatoma) 02/2023 - 09/2015
14	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2011
11	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2007
9	Infections 01/2022 - 07/2008
9	Carcinoma (Carcinomatosis) 01/2020 - 01/2002
6	Liver Neoplasms (Liver Cancer) 08/2019 - 10/2015
5	Cholangiocarcinoma 03/2021 - 12/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 05/2017
3	Disease Progression 04/2024 - 10/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2015
3	Circulating Neoplastic Cells 12/2021 - 01/2018
3	Latent Infection 09/2021 - 06/2007
3	Lymphatic Metastasis 11/2019 - 07/2005
2	Hypoxia (Hypoxemia) 02/2024 - 12/2018
2	Osteosarcoma (Osteogenic Sarcoma) 11/2023 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 03/2021
2	Triple Negative Breast Neoplasms 01/2022 - 03/2021
2	Dehydration (Water Stress) 04/2021 - 02/2009
2	Stomach Neoplasms (Stomach Cancer) 06/2020 - 01/2012
2	Metabolic Diseases (Metabolic Disease) 03/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2000
37	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023 - 05/2002
20	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2011
19	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2002
13	MicroRNAs (MicroRNA)IBA 02/2023 - 11/2011
13	Catalytic DNA (Deoxyribozyme)IBA 01/2022 - 07/2005
11	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 11/2004
9	RNA (Ribonucleic Acid)IBA 02/2023 - 11/2009
9	Messenger RNA (mRNA)IBA 01/2022 - 01/2002
8	EnzymesIBA 02/2023 - 06/2014
8	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2002
8	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 06/2003
8	NF-kappa B (NF-kB)IBA 01/2021 - 01/2002
8	ChromatinIBA 01/2020 - 04/2013
8	grifolinIBA 01/2018 - 06/2005
8	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2010 - 01/2002
7	Adenosine Triphosphate (ATP)IBA 07/2022 - 06/2014
6	Long Noncoding RNAIBA 11/2023 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 08/2014
6	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017 - 09/2005
6	Phosphotransferases (Kinase)IBA 12/2015 - 10/2007
5	Fatty Acids (Saturated Fatty Acids)IBA 11/2022 - 01/2018
5	LipidsIBA 03/2020 - 11/2017
5	CytokinesIBA 06/2019 - 01/2016
5	Protein Kinases (Protein Kinase)IBA 01/2018 - 02/2009
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2023 - 10/2015
4	ErbB Receptors (EGF Receptor)IBA 03/2021 - 05/2002
4	Chemokine ReceptorsIBA 01/2021 - 07/2005
4	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2012
3	Fetal Proteins (Fetoprotein)IBA 10/2023 - 10/2020
3	lenvatinibIBA 01/2023 - 10/2022
3	LigandsIBA 01/2023 - 07/2005
3	Tumor Biomarkers (Tumor Markers)IBA 08/2022 - 01/2010
3	Estrogen ReceptorsIBA 01/2022 - 05/2013
3	Proline (L-Proline)FDA Link 01/2022 - 01/2020
3	Nucleic AcidsIBA 12/2021 - 01/2019
3	SesquiterpenesIBA 01/2021 - 08/2015
3	trichothecinIBA 01/2021 - 07/2019
3	Competitive Endogenous RNAIBA 04/2020 - 11/2019
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 01/2017
3	TransferasesIBA 06/2019 - 01/2002
3	Interleukin-8 (Interleukin 8)IBA 06/2019 - 05/2012
3	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2008
3	Mitogen-Activated Protein Kinase 3IBA 01/2019 - 03/2013
3	Epstein-Barr virus EBV-associated membrane antigenIBA 01/2018 - 06/2003
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2018 - 07/2004
3	neoalbaconolIBA 01/2017 - 02/2015
3	Death-Associated Protein KinasesIBA 08/2015 - 01/2011
3	StathminIBA 02/2014 - 03/2009
3	ezrinIBA 10/2011 - 01/2007
2	InterferonsIBA 12/2023 - 01/2019
2	Metal-Organic FrameworksIBA 12/2023 - 10/2020
2	Peptides (Polypeptides)IBA 10/2023 - 01/2019
2	Carcinoembryonic AntigenIBA 10/2023 - 12/2017
2	CarbohydratesIBA 10/2023 - 12/2017
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
2	NADP (NADPH)IBA 10/2022 - 01/2022
2	Fumarate Hydratase (Fumarase)IBA 04/2022 - 10/2016
2	Amino Acids FDA Link 01/2022 - 03/2015
2	Glutamine (L-Glutamine)FDA Link 01/2022 - 11/2017
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 10/2010
2	Arginine (L-Arginine)FDA Link 01/2022 - 01/2013
2	Viral ProteinsIBA 12/2021 - 06/2012
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2017
2	CarcinogensIBA 12/2021 - 10/2011
2	MethyltransferasesIBA 11/2021 - 01/2017
2	CateninsIBA 01/2021 - 01/2016
2	Arsenic Trioxide (Trisenox)FDA Link 01/2021 - 09/2015
2	PolyphenolsIBA 03/2020 - 03/2013
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020 - 01/2018

Therapy/Procedure

38	Therapeutics 04/2024 - 03/2004
13	Radiotherapy 01/2024 - 06/2011
5	Immunotherapy 01/2023 - 01/2020
5	Hepatectomy 01/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2021 - 08/2015
3	Liver Transplantation 10/2022 - 01/2021